相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis
Charles Dervout et al.
ACTA DERMATO-VENEREOLOGICA (2022)
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis
Andreas E. Kremer et al.
LIVER INTERNATIONAL (2022)
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Jorn M. Schattenberg et al.
JOURNAL OF HEPATOLOGY (2021)
Naltrexone for cholestatic itch: a systematic review
Fay Louise Murray-Brown
BMJ SUPPORTIVE & PALLIATIVE CARE (2021)
Safety considerations for the management of cholestatic itch
Juan Trivella et al.
EXPERT OPINION ON DRUG SAFETY (2021)
A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
Hannah P. Kim et al.
HEPATOLOGY COMMUNICATIONS (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis
Raj A. Shah et al.
SEMINARS IN LIVER DISEASE (2019)
Effect of NGM282, an FGF19 Analogue, on Pruritus in Patients with Primary Sclerosing Cholangitis: Analysis of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Marlyn J. Mayo et al.
JOURNAL OF HEPATOLOGY (2019)
Cholestatic pruritus: Emerging mechanisms and therapeutics
Sagar P. Patel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis
Marlyn J. Mayo et al.
HEPATOLOGY COMMUNICATIONS (2019)
Comparison of Sertraline with Rifampin in the treatment of Cholestatic Pruritus: A Randomized Clinical Trial
Sara Ataei et al.
REVIEWS ON RECENT CLINICAL TRIALS (2019)
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study
G. J. Webb et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study
Minami Yagi et al.
JOURNAL OF GASTROENTEROLOGY (2018)
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience
Sara Lemoinne et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2018)
Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
Samer Al-Dury et al.
SCIENTIFIC REPORTS (2018)
Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response
Anna Reig et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double Blind Placebo Controlled Trial
Marlyn J. Mayo et al.
HEPATOLOGY COMMUNICATIONS (2018)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
Vinod S. Hegade et al.
LANCET (2017)
Recent advances in the management of pruritus in chronic liver diseases
Kazuto Tajiri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review
Hirsh D. Trivedi et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis
James H. Tabibian et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
Quality of life among patients suffering from cholestatic liver disease-induced pruritus: A systematic review
Xin Yee Jin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)
ACG Clinical Guideline: Primary Sclerosing Cholangitis
Keith D. Lindor et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Itch and liver: management in primary care
Vinod S. Hegade et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Pruritus in Cholestasis: Facts and Fiction
Ulrich Beuers et al.
HEPATOLOGY (2014)
Q-Coh: A tool to screen the methodological quality of cohort studies in systematic reviews and meta-analyses
Alexander Jarde et al.
INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY (2013)
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
C. Levy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The Potent Bile Acid Sequestrant Colesevelam Is Not Effective in Cholestatic Pruritus: Results of a Double-Blind, Randomized, Placebo-Controlled Trial
Edith M. M. Kuiper et al.
HEPATOLOGY (2010)
Sertraline as a first-line treatment for cholestatic pruritus
Marlyn J. Mayo et al.
HEPATOLOGY (2007)
Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases
AG Villamil et al.
AMERICAN JOURNAL OF MEDICINE (2005)
A controlled trial of ondansetron in the pruritus of cholestasis
JW O'Donohue et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Bezafibrate treatment: a new medical approach for PBC patients?
T Kanda et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study
R Terg et al.
JOURNAL OF HEPATOLOGY (2002)
Effects of ursodeoxycholic acid and colestilan versus ursodeoxycholic acid alone on serum bile acids and pruritus: A randomized, open-label study
H Yokomori et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2001)
分享论文
